Literature DB >> 11917949

Ca 19-9 in the monitoring of colorectal cancer after surgery.

F Franchi, C Pastore, P Izzo, E Calió.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11917949     DOI: 10.1385/MO:18:3:237

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  5 in total

1.  Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

2.  The value of follow-up after curative surgery of colorectal carcinoma.

Authors:  F Safi; H G Beyer
Journal:  Cancer Detect Prev       Date:  1993

3.  Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA.

Authors:  X Filella; R Molina; J M Piqué; J C Garcia-Valdecasas; J J Grau; F Novell; E Astudillo; A de Lacy; M Daniels; A M Ballesta
Journal:  Tumour Biol       Date:  1994

Review 4.  Carcinoembryonic antigen.

Authors:  R H Fletcher
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

5.  Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma.

Authors:  M Kouri; S Pyrhönen; P Kuusela
Journal:  J Surg Oncol       Date:  1992-02       Impact factor: 3.454

  5 in total
  2 in total

1.  High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.

Authors:  Zhenhai Lu; Jianhong Peng; Zhiqiang Wang; Zhizhong Pan; Yunfei Yuan; Desen Wan; Binkui Li
Journal:  Med Oncol       Date:  2016-10-08       Impact factor: 3.064

2.  The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.

Authors:  Ryosuke Okamura; Suguru Hasegawa; Koya Hida; Nobuaki Hoshino; Kenji Kawada; Kenichi Sugihara; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2016-08-08       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.